Trial intelligence / Profile preview

Ginseng for Cancer-Related Fatigue

NCT01375114Phase 2Active, not recruiting

Sponsor
University of Texas MD Anderson Cancer Center
Start
Oct 2011
Primary completion
May 2016
Modality
Hydrogel Systems, Transdermal Patches
Countries
1
01

Overview

A Phase 2 trial of Panax ginseng in cancer-related fatigue (CRF), sponsored by University of Texas MD Anderson Cancer Center. Started Oct 2011; status: active, not recruiting.

02

Drugs

Panax ginseng
03

Conditions

cancer-related fatigue (CRF)

Beyond the preview

Go deeper on NCT01375114.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01375114.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call